1 – 10 of 305
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
(
- Contribution to journal › Article
- 2023
-
Mark
Ganglioside GM3 stimulates lipid-protein co-assembly in α-synuclein amyloid formation
(
- Contribution to journal › Article
-
Mark
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum : Revelations from the MANAGE-PD validation cohort
(
- Contribution to journal › Article
-
Mark
Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
(
- Contribution to journal › Article
-
Mark
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers
(
- Contribution to journal › Article
-
Mark
Embracing Monogenic Parkinson's Disease : The MJFF Global Genetic PD Cohort
(
- Contribution to journal › Article
-
Mark
The etiology of Parkinson's disease. Genetic and non-genetic risk factors for a multifactorial disease
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction Are Altered in Parkinson's Disease and Related Disorders
(
- Contribution to journal › Article